Chroma Medicine

Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of genetically driven diseases.

Industries

Biotechnology

Headquarters

Cambridge, United States

Stage

Series B

Employees

11-50

Links

Org chart

Catherine Stehman-Breen

CEO

Collapse

Vic Myers

President & CSO

Brett Kaplan

CFO & Corporate Development Officer

Aron Jaffe

SVP & Head of Research

Hasit Lunagaria

SVP, People & Culture

Noah Goodman

SVP, Business Development

Warren Jaworowicz

SVP, Delivery Sciences & CMC

Andrea Sarasin

VP, Business Strategy & Integration

Bruce Ricart

VP, Program Management

Cecilia Fernandez

VP, Strategic Planning & Operations

Tobias Brambrink

VP, Intellectual Property

Kunza Ahmad

Research Associate

Teams

View all

+14

Leadership Team

17 members

Board of Directors

10 members

CEO and Executive Team

7 members

Founding Team

6 members

Discover similar companies

Xontogeny

Boston, United States · Series A

Neogene Therapeutics

New York, United States · Series A

X-Vax Technology

Jupiter, United States · Series A

Gameto

New York, United States · Venture

Primmune Therapeutics

San Diego, United States · Series A

Kula Bio

Somerville, United States · Series A

Dianthus Therapeutics

Waltham, United States · Series A

RosVivo Therapeutics

Reno, United States · Venture

Entos

San Diego, United States · Seed

Swiftline

New York, United States · Series A

Synthesis

San Mateo, United States · Venture

CytoKi Pharma

Værløse, Denmark · Series A

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.